These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7888109)
21. A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25-35-impaired mouse cognitive function. Zhang Z; Chen R; An W; Wang C; Liao G; Dong X; Bi A; Yin Z; Luo L Psychopharmacology (Berl); 2016 Feb; 233(4):599-613. PubMed ID: 26554390 [TBL] [Abstract][Full Text] [Related]
22. Involvement of the sigma1 (sigma1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41. Espallergues J; Lapalud P; Christopoulos A; Avlani VA; Sexton PM; Vamvakides A; Maurice T Br J Pharmacol; 2007 Sep; 152(2):267-79. PubMed ID: 17641675 [TBL] [Abstract][Full Text] [Related]
23. Differential muscarinic receptor binding of acetylcholinesterase inhibitors in rat brain, human brain and Chinese hamster ovary cells expressing human receptors. Van Den Beukel I; Dijcks FA; Vanderheyden P; Vauquelin G; Oortgiesen M J Pharmacol Exp Ther; 1997 Jun; 281(3):1113-9. PubMed ID: 9190843 [TBL] [Abstract][Full Text] [Related]
24. The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release. Johnson DE; Nedza FM; Spracklin DK; Ward KM; Schmidt AW; Iredale PA; Godek DM; Rollema H Eur J Pharmacol; 2005 Jan; 506(3):209-19. PubMed ID: 15627430 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo. Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain. Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753 [TBL] [Abstract][Full Text] [Related]
27. Exogenous activation of muscarinic receptors decreases subsequent non-muscarinic bladder contractions in vivo in the female rat. Kullmann FA; Wells GI; McKenna DG; Thor KB Life Sci; 2013 Apr; 92(12):733-9. PubMed ID: 23399698 [TBL] [Abstract][Full Text] [Related]
28. Fluorescent styryl dyes FM1-43 and FM2-10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy. Mazzone SB; Mori N; Burman M; Palovich M; Belmonte KE; Canning BJ J Physiol; 2006 Aug; 575(Pt 1):23-35. PubMed ID: 16728454 [TBL] [Abstract][Full Text] [Related]
30. In vitro functional interactions of acetylcholine esterase inhibitors and muscarinic receptor antagonists in the urinary bladder of the rat. Killi UK; Wsol V; Soukup O; Kuca K; Winder M; Tobin G Clin Exp Pharmacol Physiol; 2014 Feb; 41(2):139-46. PubMed ID: 24341923 [TBL] [Abstract][Full Text] [Related]
31. Presence of cholinomimetic and acetylcholinesterase inhibitory constituents in betel nut. Gilani AH; Ghayur MN; Saify ZS; Ahmed SP; Choudhary MI; Khalid A Life Sci; 2004 Oct; 75(20):2377-89. PubMed ID: 15350815 [TBL] [Abstract][Full Text] [Related]
32. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Volpicelli-Daley LA; Hrabovska A; Duysen EG; Ferguson SM; Blakely RD; Lockridge O; Levey AI Mol Pharmacol; 2003 Dec; 64(6):1309-16. PubMed ID: 14645660 [TBL] [Abstract][Full Text] [Related]
34. Altered hippocampal muscarinic receptors in acetylcholinesterase-deficient mice. Volpicelli-Daley LA; Duysen EG; Lockridge O; Levey AI Ann Neurol; 2003 Jun; 53(6):788-96. PubMed ID: 12783426 [TBL] [Abstract][Full Text] [Related]
35. Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems. Noda Y; Mouri A; Ando Y; Waki Y; Yamada SN; Yoshimi A; Yamada K; Ozaki N; Wang D; Nabeshima T Int J Neuropsychopharmacol; 2010 Nov; 13(10):1343-54. PubMed ID: 20219155 [TBL] [Abstract][Full Text] [Related]
36. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors. Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710 [TBL] [Abstract][Full Text] [Related]
37. Regulation of M1-receptor mRNA stability by smilagenin and its significance in improving memory of aged rats. Hu Y; Wang Z; Zhang R; Wu P; Xia Z; Orsi A; Rees D Neurobiol Aging; 2010 Jun; 31(6):1010-9. PubMed ID: 18676061 [TBL] [Abstract][Full Text] [Related]
38. Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism. Giorgetti M; Gibbons JA; Bernales S; Alfaro IE; Drieu La Rochelle C; Cremers T; Altar CA; Wronski R; Hutter-Paier B; Protter AA J Pharmacol Exp Ther; 2010 Jun; 333(3):748-57. PubMed ID: 20194526 [TBL] [Abstract][Full Text] [Related]